SelectQuote, Inc. Q4 2026 Earnings Call Summary
SelectQuote, Inc. reported Q4 2026 earnings, focusing on cash flow and leverage reduction. Healthcare Services became the largest revenue contributor with a $50M EBITDA run rate. Fiscal 2027 revenue is projected to decline 14% due to Medicare Advantage policy drops and the Inflation Reduction Act. Operating cash flow is expected to double to $60M, with free cash flow targeted at $50M. The company plans to reduce debt and invest in technology for efficiency gains.
How this was made

The 30-second read
Why it matters
Management emphasizes cash‑flow generation, leverage reduction, and AI‑enabled efficiency gains.
Market read
Earnings call provides fresh guidance and operational metrics that may influence the stock and sector sentiment.
What to watch
Potential upside from AI‑driven cost reductions and future refinancing of high‑cost debt.
Background
SelectQuote, a U.S. health‑insurance brokerage, discussed Q4 2026 results and FY2027 outlook.
Market effects
Provides insight into Medicare Advantage and healthcare services sector outlook.
Impacts U.S. healthcare services and insurance markets.
Limited to U.S. insurers; minimal global effect.
Counterpoint
Guidance suggests revenue decline, but cash flow improvements could attract value‑focused investors.
Key entities
- companySelectQuote, Inc.
U.S. health‑insurance brokerage providing Medicare Advantage and term‑life products.



